182 related articles for article (PubMed ID: 3484714)
21. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
[TBL] [Abstract][Full Text] [Related]
22. [Effect of phentolamine in combination with pituitrin on the hepatic and systemic hemodynamics].
Dan Z
Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):367-9, 26. PubMed ID: 1699642
[TBL] [Abstract][Full Text] [Related]
23. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
Lebrec D
Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
[TBL] [Abstract][Full Text] [Related]
24. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model.
Dan ZL; Zhao Q; Li SB
J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450
[TBL] [Abstract][Full Text] [Related]
25. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
26. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Bosch J; Masti R; Kravetz D; Bruix J; Gaya J; Rigau J; Rodes J
Hepatology; 1984; 4(6):1200-5. PubMed ID: 6500511
[TBL] [Abstract][Full Text] [Related]
27. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
[TBL] [Abstract][Full Text] [Related]
28. Propranolol--a medical treatment for portal hypertension?
Lebrec D; Nouel O; Corbic M; Benhamou JP
Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
[TBL] [Abstract][Full Text] [Related]
29. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
32. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
33. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
34. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension.
Burns RC; Wu Y; Sitzmann JV
Surgery; 1995 May; 117(5):488-93. PubMed ID: 7740418
[TBL] [Abstract][Full Text] [Related]
35. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
37. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
38. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
39. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J
J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394
[TBL] [Abstract][Full Text] [Related]
40. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
